Paolo Sportoletti, MD

Associate Professor
A.O. Santa Maria della Misericordia di Perugia
Perugia, Umbria, Italy

NA

Presentation(s):

• (1498877) XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling

  Friday, October 6, 2023
  11:35 AM – 11:40 AM EDT

• (1552495) Impact of COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study.

  Friday, October 6, 2023
  1:50 PM – 1:55 PM EDT